MULTIMODAL therapy demonstrates superior efficacy in managing allergic rhinitis, significantly reducing symptom relief times and improving treatment outcomes compared to standard care.
Allergic rhinitis, characterised by nasal congestion, itching, rhinorrhoea, and sneezing, is a common inflammatory condition often triggered by allergens. Its management typically involves pharmacological interventions aimed at symptom relief. However, the effectiveness of conventional treatments varies, and many patients continue to experience a diminished quality of life. This study aimed to evaluate the benefits of a multimodal therapy protocol compared to standard treatment for allergic rhinitis, exploring its potential to offer enhanced relief and better outcomes.
A randomised controlled trial was conducted with 100 participants diagnosed with allergic rhinitis. Patients were evenly divided into an experimental group, which received multimodal therapy, and a control group, which received standard care. Symptom relief times and treatment effectiveness were assessed using standardised questionnaires. The experimental group demonstrated significantly shorter symptom relief times: nasal itching (3.16 ± 0.45 days vs. 5.13 ± 0.77 days), nasal congestion (2.68 ± 0.55 days vs. 4.35 ± 0.71 days), rhinorrhoea (2.51 ± 0.23 days vs. 4.85 ± 0.63 days), and sneezing (3.41 ± 0.31 days vs. 6.73 ± 0.99 days). The experimental group’s total effective rate was 90.0%, markedly higher than the control group’s 66.0% (P < 0.05).
These findings underscore the potential of multimodal therapy to provide faster symptom relief and greater overall treatment success in allergic rhinitis. The integration of various therapeutic approaches appears to address the multifaceted nature of the condition more comprehensively than standard methods. For clinical practice, these results highlight the need to consider multimodal interventions as a primary treatment option for patients with allergic rhinitis. Further research could refine the components of multimodal therapy and investigate its applicability across diverse patient populations, ensuring broader adoption and optimisation of care protocols.
Abigail Craig, EMJ
Reference
Yu Y and Yan J. Effectiveness of a multimodal therapy protocol for the management of allergic rhinitis: a randomized controlled trial. Eur J Med Res. 2024;29(1):607.
